【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1323次   下载 144  
喉癌组织中P16蛋白表达的检测及临床相关性研究
范静平,萧璧君,廖建春,吕春雷
0
()
摘要:
目的:探讨喉鳞状细胞癌中P16蛋白表达的情况及临床相关性。方法:用免疫组化的方法检测42例喉鳞癌组织中P16蛋白的表达情况。结果:P16蛋白表达的阳性率为47.62%(20/42)。其中声门上型组为40.00%(4/10),声门型组为57.89%(11/19),声门下型组为38.46%(5/13);细胞分化Ⅰ级组为75.00%(12/16),Ⅱ?Ⅲ级组为30.77%(8/26);伴有颈淋巴结转移组为20.00%(3/15),无颈淋巴结转移组为62.96%(17/27);临床Ⅰ期组为40.00%(8/20),Ⅱ?Ⅳ期组为54.54%(12/22)。结论:提示P16蛋白的表达与癌细胞的分化程度及肿瘤的转移情况有关,与临床分型及分期无关。
关键词:  喉肿瘤  基因,p16
DOI:
基金项目:
Examination of P16 protein expression in human laryngeal carcinoma and study of its clinical correlation
范静平,萧璧君,廖建春,吕春雷
()
Abstract:
Objective:To study the expression of P16 gene and its correlation with clinical cases. Methods:The levels of P16 gene products were examined immunochemically in resected specimens of human laryngeal squamous cell carcinoma. Results: Carcinomas tested: 47.62%(20/42) showed positive staining in the lesions. 40.00%(4/10) in supraglottic cancer group, 57.89%(11/19) in glottic cancer group, 38.46%(5/13) in subglottic cancer group, 75.00%(12/16) in cell differentiation gradeⅠgroup, 30.77%(8/26) in cell differentiation grade Ⅱ?Ⅲ group, 20.00%(3/15) in lymph node metastasis group, 62.96%(17/27) in those without metastasis, 40.00%(8/20) in clinical stageⅠgroup, 54.54%(12/22) in stageⅡ?Ⅳgroup. Conclusion:The expression of P16 protein is related with malignant degree and lymph metastasis in human laryngeal carcinoma.
Key words:  laryngeal neoplasms  gene, P16